Dr. Ciezki on Common Advanced Disease Sites in Patients

Video

Jay Ciezki, MD, Department of Radiation Oncology, Cleveland Clinic, discusses an analysis of patients with various malignancies who commonly presented with advanced disease.

Jay Ciezki, MD, Department of Radiation Oncology, Cleveland Clinic, discusses an analysis of patients with various malignancies who commonly presented with advanced disease.

In clinical practice, Ciezki says he has noticed more patients presenting with advanced disease over the last 2 to 3 years. To gain a deeper understanding of this occurrence, Ciezki and other researchers examined a 20-year database of patients and the stage they presented with.

As a result of the query, Ciezki concluded that more patients presented with advanced stage disease in the last 2 to 3 years compared with patient visits from earlier years. The tumor type that was found to be most commonly presented as advanced was prostate cancer. This is interesting, Ciezki says, because prostate cancer is very screenable, treatable, and curable.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Elias Jabbour, MD